Ralliant Corporation (NYSE:RAL) Given Average Recommendation of “Hold” by Analysts

Shares of Ralliant Corporation (NYSE:RAL) have been given an average rating of “Hold” by the twelve analysts that are presently covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a sell recommendation, three have issued a hold recommendation and seven have assigned a buy recommendation to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $50.50.

Several equities analysts have recently issued reports on the company. Weiss Ratings cut Ralliant from a “hold (c)” rating to a “sell (d)” rating in a research note on Thursday, February 5th. Truist Financial dropped their price target on Ralliant from $62.00 to $49.00 and set a “buy” rating for the company in a research note on Friday, February 6th. Barclays cut their price target on shares of Ralliant from $60.00 to $52.00 and set an “overweight” rating on the stock in a report on Monday, February 9th. Zacks Research lowered shares of Ralliant from a “hold” rating to a “strong sell” rating in a report on Monday, February 9th. Finally, Oppenheimer dropped their target price on shares of Ralliant from $60.00 to $50.00 and set an “outperform” rating for the company in a research report on Friday, February 6th.

Insiders Place Their Bets

In other news, SVP Amir A. Kazmi bought 2,545 shares of the stock in a transaction dated Friday, February 6th. The stock was bought at an average price of $39.27 per share, for a total transaction of $99,942.15. Following the purchase, the senior vice president directly owned 39,699 shares in the company, valued at $1,558,979.73. This trade represents a 6.85% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Kevin E. Bryant purchased 1,250 shares of Ralliant stock in a transaction that occurred on Friday, February 6th. The stock was purchased at an average cost of $39.97 per share, for a total transaction of $49,962.50. Following the completion of the purchase, the director owned 4,653 shares of the company’s stock, valued at $185,980.41. This trade represents a 36.73% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders bought a total of 8,145 shares of company stock valued at $332,233 over the last ninety days.

Hedge Funds Weigh In On Ralliant

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Danske Bank A S purchased a new stake in shares of Ralliant in the 4th quarter worth about $25,000. Westfuller Advisors LLC purchased a new position in Ralliant during the 3rd quarter valued at about $26,000. V Square Quantitative Management LLC bought a new stake in Ralliant during the fourth quarter worth about $26,000. Allworth Financial LP boosted its stake in Ralliant by 134.4% during the fourth quarter. Allworth Financial LP now owns 511 shares of the company’s stock worth $26,000 after acquiring an additional 293 shares in the last quarter. Finally, Palisade Asset Management LLC purchased a new stake in Ralliant in the third quarter worth about $26,000.

Ralliant Stock Down 4.1%

NYSE RAL opened at $41.02 on Friday. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.84 and a quick ratio of 0.58. The stock has a market capitalization of $4.58 billion and a PE ratio of 20.93. Ralliant has a 1 year low of $37.27 and a 1 year high of $57.02. The business’s 50-day moving average is $46.43 and its 200 day moving average is $46.68.

Ralliant (NYSE:RAL) last released its quarterly earnings results on Wednesday, February 4th. The company reported $0.69 EPS for the quarter, beating analysts’ consensus estimates of $0.67 by $0.02. The business had revenue of $554.60 million for the quarter, compared to the consensus estimate of $543.04 million. The firm’s revenue for the quarter was up 1.2% on a year-over-year basis. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, March 23rd. Investors of record on Monday, March 9th were paid a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date of this dividend was Monday, March 9th. Ralliant’s dividend payout ratio is presently 10.20%.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.